Yale Astronomers Questioned Systemic Racism Because They Hired One Black Employee 35 Years Ago, Emails Show
“Deeply entrenched systemic racism exists in every sector of our society, including at Yale and in this department,” a group of undergraduates wrote in response.
“Healthcare providers and hospitals in Arizona are issuing dire warnings,” one state representative said. “I sure hope Governor Ducey is listening.”
“It’s like the guy went crazy with Photoshop,” said one expert in scientific image manipulation.
The study has been retracted by scientists who say they can no longer vouch for its data.
“I’m an African American first before I’m a physician,” one doctor said.
Scientists Worldwide Are Questioning A Massive Study That Raised Concerns About The Malaria Drug Hyped As A COVID-19 Treatment
The study, which found that patients treated with hydroxychloroquine were more likely to die, just got a correction, though its conclusions remain unchanged.
Public health experts are accusing the CDC of bending under political pressure to say the coronavirus is less deadly.
A Stanford whistleblower complaint alleges that the controversial John Ioannidis study failed to disclose important financial ties and ignored scientists’ concerns that their antibody test was inaccurate.
The agency had previously relaxed its rules for verifying manufacturers’ accuracy data, leading more than 165 unauthorized tests to flood the US market.
Facing low sales and trouble from regulators, the e-cigarette giant is planning to be off shelves in Austria, Belgium, Portugal, France, and Spain by the end of the year.
Without enough human contact tracers to identify infected people, the US is barreling toward a digital solution, and possible disaster.
A Stanford Professor’s Wife Recruited People For His Coronavirus Study By Claiming It Would Reveal If They Could “Return To Work Without Fear”
An email sent to a Silicon Valley middle school’s private listserv tried to recruit families for the antibody study, promising “peace of mind” about their immunity to the coronavirus.
In California, two of the nation’s first big antibody surveys estimated that the true number of coronavirus infections is significantly higher than believed. But scientists are skeptical.
“I think we should expect to see companies continue to pop up selling unproven, and in some cases probably just bad, testing,” a former FDA lawyer said.
Coronavirus Antibody Tests Could Help Us Get Back To Normal — Or They Could Be The Next Testing Crisis
Hospitals and clinics are rushing to use antibody tests in an effort to determine who is immune to the coronavirus. But almost none of them have been verified by the FDA.
The Federal Government Is Planning To Order 5-Minute Coronavirus Tests — But Not Nearly Enough For Everyone Who Needs One
The White House has said the machine will revolutionize the beleaguered testing system in the US. But the feds have only planned to order enough tests for up to 5,500 people, according to emails obtained by BuzzFeed News.
People with no COVID-19 symptoms may be spreading the disease — but big questions remain about how much they are driving the pandemic.
More than a year after Altria took a one-third stake in Juul, valuing the e-cigarette company at $38 billion, the FTC is seeking to unwind the deal.
It’s the latest high-profile departure for the e-cigarette manufacturer.
This week, researchers in New York City started collecting blood from COVID-19 survivors. The hope is that their immunity can be shared with others.